[1] 宋敏, 陆普选, 方伟军, 等. 2022年WHO全球结核病报告:全球与中国关键数据分析[J]. 新发传染病电子杂志, 2023,8(1):87-92.
[2] Eribo OA, du Plessis N, Ozturk M, et al. The gut microbiome in tuberculosis susceptibility and treatment response: Guilty or not guilty?[J] Cell Mol Life Sci, 2020,77(8):1497-1509.
[3] Desai M, Oppenheimer J.Elucidating asthma phenotypes and endotypes: Progress towards personalized medicine[J]. Ann Allergy Asthma Immunol, 2016,116(5):394-401.
[4] Almeida A, Mitchell AL, Boland M, et al.A new genomic blueprint of the human gut microbiota[J]. Nature, 2019,568(7753):499-504.
[5] Marsland BJ, Trompette A, Gollwitzer ES.The gut-lung axis in respiratory disease[J]. Ann Am Thorac Soc, 2015(Suppl 2):S150-156.
[6] Thornton CS, Mellett M, Jarand J, et al.The respiratory microbiome and nontuberculous mycobacteria: An emerging concern in human health[J]. Eur Respir Rev, 2021,30(160):200299.
[7] Barcik W, Boutin RCT, Sokolowska M, et al.The role of lung and lut microbiota in the pathology of asthma[J]. Immunity, 2020,52(2):241-255.
[8] Segal LN, Alekseyenko AV, Clemente JC, et al.Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation[J].Microbiome, 2013,1(1):19.
[9] Iwase T, Uehara Y, Shinji H, et al.Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization[J]. Nature, 2010,465(7296):346-349.
[10] Enaud R, Prevel R, Ciarlo E, et al.The gut-lung axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks[J]. Front Cell Infect Microbiol, 2020,10:9.
[11] Marsland BJ, Gollwitzer ES.Host-microorganism interactions in lung diseases[J]. Nat Rev Immunol, 2014,14(12):827-35.
[12] Sze MA, Tsuruta M, Yang SW, et al.Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs[J]. PLoS One, 2014,9(10):e111228.
[13] Namasivayam S, Sher A, Glickman MS, et al.The microbiome and tuberculosis: Early evidence for cross talk[J]. mBio, 2018,9(5).
[14] Verheijden K, Van Bergenhenegouwen J, Garssen J, et al.Treatment with specific prebiotics or probiotics prevents the development of lung emphysema in a mouse model of COPD[J]. Eur J Pharmacol, 2011(668):e12-e13.
[15] Zhuang H, Cheng L, Wang Y, et al.Dysbiosis of the gut microbiome in lung cancer[J]. Front Cell Infect Microbiol, 2019,9:112.
[16] Soret P, Vandenborght LE, Francis F, et al.Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis[J]. Sci Rep, 2020,10(1):3589.
[17] Brown RL, Sequeira RP, Clarke TB.The microbiota protects against respiratory infection via GM-CSF signaling[J]. Nat Commun, 2017,8(1):1512.
[18] Budden KF, Gellatly SL, Wood DL, et al.Emerging pathogenic links between microbiota and the gut-lung axis[J]. Nat Rev Microbiol, 2017,15(1):55-63.
[19] He Y, Wen Q, Yao F, et al.Gut-lung axis: The microbial contributions and clinical implications[J]. Crit Rev Microbiol, 2017,43(1):81-95.
[20] Perrone EE, Jung E, Breed E, et al.Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis[J]. Shock, 2012,38(1):68-75.
[21] Coopersmith CM, Stromberg PE, Davis CG, et al.Sepsis from pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest[J]. Crit Care Med, 2003: 31, 1630-1637.
[22] 司秀影, 李勇军, 史梦迪, 等. 基于“肺-肠”轴探讨肠道微生态与支气管哮喘的关系[J]. 中华中医药学刊, 2022,40(9):163-166.
[23] Hu Y, Feng Y, Wu J, et al.The gut microbiome signatures discriminate healthy from pulmonary tuberculosis patients[J]. Front Cell Infect Microbiol, 2019,9:90.
[24] Parikh A, Vinnard C, Fahrenfeld N, et al.Revisiting John Snow to meet the challenge of nontuberculous mycobacterial lung disease[J]. Int J Environ Res Public Health, 2019,16(21):4250.
[25] Winglee K, Eloe-Fadrosh E, Gupta S, et al. Aerosol mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiota[J]. PLoS One, 2014,9(5):e97048.
[26] Arias L, Goig GA, Cardona P, et al.Influence of gut microbiota on progression to tuberculosis generated by high fat diet-induced obesity in C3HeB/FeJ mice[J]. Front Immunol, 2019,10:2464.
[27] Hu Y, Yang Q, Liu B, et al.Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs[J]. J Infect, 2019,78(4):317-322.
[28] Balcells ME, Yokobori N, Hong BY, et al.The lung microbiome, vitamin D, and the tuberculous granuloma: A balance triangle[J]. Microb Patho, 2019,131:158-163.
[29] 王侠, 陆军, 胡韵, 等. 辅助性T细胞分泌的细胞因子在结核病中的作用研究进展[J]. 中华医院感染学杂志, 2022,32(12):1911-1916.
[30] Amaral EP, Vinhaes CL, Oliveira-de-Souza D, et al. The interplay between systemic inflammation, oxidative stress, and tissue remodeling in tuberculosis[J]. Antioxid Redox Signal, 2021,34(6):471-485.
[31] Wu J, Liu W, He L, et al.Sputum microbiota associated with new, recurrent and treatment failure tuberculosis[J]. PLoS One, 2013,8(12):e83445.
[32] Zhang M, Shen L, Zhou X, et al.The microbiota of human lung of pulmonary tuberculosis and the alteration caused by anti-tuberculosis drugs[J]. Curr Microbiol, 2022,79(11):321.
[33] Huang SF, Yang YY, Chou KT, et al.Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans[J]. Eur J Clin Invest, 2019,49(5):e13068.
[34] Wang Y, Deng Y, Liu N, et al.Alterations in the gut microbiome of individuals with tuberculosis of different disease states[J]. Front Cell Infect Microbiol, 2022,12:836987.
[35] Luo M, Liu Y, Wu P, et al.Alternation of gut microbiota in patients with pulmonary tuberculosis[J]. Front Physiol, 2017,8:822.
[36] 曹振辉, 刘永仕, 潘洪彬, 等. 乳酸菌的益生功能及作用机制研究进展[J]. 食品工业科技, 2015,36(24):366-370, 377.
[37] Manos J, Hu H, Rose BR, et al.Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.[J]. Eur J Clin Microbiol Infect Dis, 2013,32(12):1583-1592.
[38] Holm JP, Hilberg O, Noerskov-Lauritsen N, et al. Pseudomonas aeruginosa in patients without cystic fibrosis is strongly associated with chronic obstructive lung disease[J]. Dan Med J, 2013,60(6):A4636.
[39] Zakharkina T, Heinzel E, Koczulla RA, et al.Analysis of the airway microbiota of healthy individuals and patients with chronic obstructive pulmonary disease by T-RFLP and clone sequencing[J]. PLoS One, 2013,8(7):e68302.
[40] Comberiati P, Di Cicco M, Paravati F, et al.The role of gut and lung microbiota in susceptibility to tuberculosis[J]. Int J Environ Res Public Health, 2021,18(22):12220.
[41] Wipperman MF, Fitzgerald DW, Juste MAJ, et al.Antibiotic treatment for tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed[J]. Sci Rep, 2017,7(1):10767.
[42] Negi S, Pahari S, Bashir H, et al.Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice[J]. Eur J Immunol, 2020,50(12):1976-1987.
[43] Young C, Walzl G, Du Plessis N.Therapeutic host-directed strategies to improve outcome in tuberculosis[J]. Mucosal Immunol, 2020,13(2):190-204.
[44] Gibson GR, Roberfroid MB.Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics[J]. J Nutr, 1995,125(6):1401-1412.
[45] Gibson GR, Hutkins R, Sanders ME, et al.Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics[J]. Nat Rev Gastroenterol Hepatol, 2017,14(8):491-502.
[46] Swanson KS, Gibson GR, Hutkins R, et al.The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics[J]. Nat Rev Gastroenterol Hepatol, 2020,17(11):687-701.
[47] Protsyuk R, Omelchuk S, Galan I.Nutritional correction of protein metabolism as a method of secondary prevention in patients with pulmonary tuberculosis[J]. Mod Trends Sci Prac, 2021,1,52-60.
[48] Azad MAK, Sarker M, Li T, et al.Probiotic species in the modulation of gut microbiota: An overview[J]. Biomed Res Int, 2018,2018:1-8.
[49] Gavrilova NN,Ratnikova IA,Sadanov AK,et al.Application of probiotics in complex treatment of tuberculosis[J]. Int J Eng Res Appl, 2014(4):13-18.
[50] Bravo M, Combes T, Martinez FO, et al.Lactobacilli isolated from wild boar (sus scrofa) antagonize Mycobacterium bovis Bacille Calmette-Guerin (BCG) in a species-dependent manner[J]. Front Microbiol, 2019,10:1663.
[51] Budden KF, Shukla SD, Rehman SF, et al.Functional effects of the microbiota in chronic respiratory disease[J]. Lancet Respir Med, 2019,7(10):907-920.
[52] Negatu DA, Yamada Y, Xi Y, et al.Gut microbiota metabolite indole propionic acid targets tryptophan biosynthesis in Mycobacterium tuberculosis[J]. mBio, 2019,10(2).
[53] Shah T, Shah Z, Baloch Z, et al.The role of microbiota in respiratory health and diseases,particularly in tuberculosis[J]. Biomed Pharmacother, 2021,143:112108. |
